Glucagon-like peptide-1 receptor agonists for weight loss in end-stage heart failure patients considered for heart transplantation

Severe obesity is a relative exclusion criterion for heart transplantation. This study assessed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for weight loss as a bridge to heart transplantation candidacy. A retrospective study of end-stage heart failure (ESHF) outpatients commenced on semag...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Sambavan Jeyakumar, BMed, MD, Ragavi Jeyakumar, BMed, MD, Hunter Eckford, BMedSc, Desiree Robson, RN, Liarna Honeysett, RN, Lisa Raven, MBBS, Ricardo Deveza, MD, Andrew Jabbour, MBBS, PhD, Eugene Kotlyar, MBBS, MD, Anne Keogh, MBBS, MD, Jerry R. Greenfield, MBBS, PhD, Peter Macdonald, MD, PhD, Christopher Hayward, MBBS, MD, Kavitha Muthiah, MBChB, PhD
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Elsevier 2026-08-01
سلاسل:	JHLT Open
الموضوعات:	Heart transplantation Transplant candidacy GLP-1 receptor agonists Weight loss Pre-transplant optimization
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2950133426000807
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!